LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review.

    Zulhendri, Felix / Ravalia, Munir / Kripal, Krishna / Chandrasekaran, Kavita / Fearnley, James / Perera, Conrad O

    Antioxidants (Basel, Switzerland)

    2021  Volume 10, Issue 3

    Abstract: ... article attempts to analyze the potential use of propolis in metabolic syndrome (MetS) and its associated ... is potentially useful in ameliorating the symptoms of MetS and its associated chronic diseases ... Propolis inhibits the development and manifestation of MetS and its chronic diseases by inhibiting ...

    Abstract Propolis is a resinous product collected by bees from plants to protect and maintain the homeostasis of their hives. Propolis has been used therapeutically by humans for centuries. This review article attempts to analyze the potential use of propolis in metabolic syndrome (MetS) and its associated chronic diseases. MetS and its chronic diseases were shown to be involved in at least seven out of the top 10 causes of death in 2019. Patients with MetS are also at a heightened risk of severe morbidity and mortality in the present COVID-19 pandemic. Propolis with its antioxidant and anti-inflammatory properties is potentially useful in ameliorating the symptoms of MetS and its associated chronic diseases. The aim of this article is to provide a comprehensive review on propolis and its therapeutic benefit in MetS and its chronic diseases, with an emphasis on in vitro and in vivo studies, as well as human clinical trials. Moreover, the molecular and biochemical mechanisms of action of propolis are also discussed. Propolis inhibits the development and manifestation of MetS and its chronic diseases by inhibiting of the expression and interaction of advanced glycation end products (AGEs) and their receptors (RAGEs), inhibiting pro-inflammatory signaling cascades, and promoting the cellular antioxidant systems.
    Language English
    Publishing date 2021-02-26
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox10030348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review

    Zulhendri, Felix / Ravalia, Munir / Kripal, Krishna / Chandrasekaran, Kavita / Fearnley, James / Perera, Conrad O.

    Antioxidants. 2021 Feb. 26, v. 10, no. 3

    2021  

    Abstract: ... article attempts to analyze the potential use of propolis in metabolic syndrome (MetS) and its associated ... is potentially useful in ameliorating the symptoms of MetS and its associated chronic diseases ... Propolis inhibits the development and manifestation of MetS and its chronic diseases by inhibiting ...

    Abstract Propolis is a resinous product collected by bees from plants to protect and maintain the homeostasis of their hives. Propolis has been used therapeutically by humans for centuries. This review article attempts to analyze the potential use of propolis in metabolic syndrome (MetS) and its associated chronic diseases. MetS and its chronic diseases were shown to be involved in at least seven out of the top 10 causes of death in 2019. Patients with MetS are also at a heightened risk of severe morbidity and mortality in the present COVID-19 pandemic. Propolis with its antioxidant and anti-inflammatory properties is potentially useful in ameliorating the symptoms of MetS and its associated chronic diseases. The aim of this article is to provide a comprehensive review on propolis and its therapeutic benefit in MetS and its chronic diseases, with an emphasis on in vitro and in vivo studies, as well as human clinical trials. Moreover, the molecular and biochemical mechanisms of action of propolis are also discussed. Propolis inhibits the development and manifestation of MetS and its chronic diseases by inhibiting of the expression and interaction of advanced glycation end products (AGEs) and their receptors (RAGEs), inhibiting pro-inflammatory signaling cascades, and promoting the cellular antioxidant systems.
    Keywords COVID-19 infection ; antioxidants ; death ; homeostasis ; humans ; metabolic syndrome ; morbidity ; mortality ; propolis ; risk ; therapeutics
    Language English
    Dates of publication 2021-0226
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox10030348
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top